Herein we analyzed SMOX and SUCLG2 expression trends in pan-cancer and explored the association of SMOX and SUCLG2 with cancer prognosis, immunity, cancer cell characteristics, and drug sensitivity. This evidence concerns the gene SMOX and cancer.